Amneal Pharmaceuticals, Inc. financial data

Symbol
AMRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
400 Crossing Boulevard, 3 Rd Floor, Bridgewater, NJ
Fiscal year end
December 31
Former names
Atlas Holdings, Inc. (to 4/13/2018)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 160 % -12%
Quick Ratio 64.8 % -8.2%
Return On Equity -1.28K % -14372%
Return On Assets -4.81 % -1130%
Operating Margin 6.72 % -20.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 310M shares
Entity Public Float 464M USD -1.44%
Weighted Average Number of Shares Outstanding, Basic 309M shares +101%
Weighted Average Number of Shares Outstanding, Diluted 319M shares +106%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.6B USD +12.4%
Research and Development Expense 163M USD -3.45%
Operating Income (Loss) 175M USD -10.4%
Nonoperating Income (Expense) -290M USD -61.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -116M USD -883%
Income Tax Expense (Benefit) 17.6M USD +414%
Net Income (Loss) Attributable to Parent -170M USD -1058%
Earnings Per Share, Basic -0.79 USD/shares -3850%
Earnings Per Share, Diluted -0.79 USD/shares -3850%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43.8M USD -59.9%
Accounts Receivable, after Allowance for Credit Loss, Current 546M USD +1.38%
Inventory, Net 576M USD +4.55%
Assets, Current 1.49B USD +4.48%
Property, Plant and Equipment, Net 425M USD -7.35%
Operating Lease, Right-of-Use Asset 43.3M USD -22.9%
Intangible Assets, Net (Excluding Goodwill) 820M USD -19.2%
Goodwill 599M USD -0.11%
Other Assets, Noncurrent 77M USD -17.4%
Assets 3.51B USD -5.16%
Accounts Payable, Current 200M USD +43%
Employee-related Liabilities, Current 60.6M USD +32.8%
Liabilities, Current 1.11B USD +43.4%
Other Liabilities, Noncurrent 41.5M USD +26.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -30.4M USD -477%
Retained Earnings (Accumulated Deficit) -576M USD -43.5%
Stockholders' Equity Attributable to Parent -57.5M USD -118%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -57.5M USD -138%
Liabilities and Equity 3.51B USD -5.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.41M USD -103%
Net Cash Provided by (Used in) Financing Activities -23.2M USD -79.5%
Net Cash Provided by (Used in) Investing Activities -19.8M USD -68.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -47.5M USD -141%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 49.6M USD -56.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 64.5M USD +57.1%
Deferred Tax Assets, Valuation Allowance 566M USD +29.9%
Deferred Tax Assets, Gross 567M USD +30.3%
Operating Lease, Liability 48.9M USD -17.4%
Payments to Acquire Property, Plant, and Equipment 9.2M USD -5.06%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -214M USD -4298%
Lessee, Operating Lease, Liability, to be Paid 61.3M USD -19.3%
Property, Plant and Equipment, Gross 956M USD +4.35%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.5M USD -12.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 16M USD +0.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.4M USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.7M USD -25%
Deferred Tax Assets, Operating Loss Carryforwards 74.3M USD -9.71%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 3.74M USD +3.29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.74M USD -25.5%
Additional Paid in Capital 546M USD -22.9%
Amortization of Intangible Assets 161M USD -5.73%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%